Sirona Biochem (TSXV:SBM) LT-Debt-to-Total-Asset : 2.22 (As of Jan. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Sirona Biochem's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 2.22.

Sirona Biochem's long-term debt to total assets ratio increased from Jan. 2023 (0.14) to Jan. 2024 (2.22). It may suggest that Sirona Biochem is progressively becoming more dependent on debt to grow their business.

Sirona Biochem LT-Debt-to-Total-Asset Historical Data

The historical data trend for Sirona Biochem's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem LT-Debt-to-Total-Asset Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.25

0.44

0.40

0.08

1.49

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.14	1.01	1.42	1.49	2.22

Sirona Biochem LT-Debt-to-Total-Asset Calculation

Sirona Biochem's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Oct. 2023 is calculated as

LT Debt to Total Assets (A: Oct. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Oct. 2023 )	/	Total Assets (A: Oct. 2023 )
	=	1.539	/	1.032
	=	1.49

Sirona Biochem's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )	/	Total Assets (Q: Jan. 2024 )
	=	1.556	/	0.701
	=	2.22

Sirona Biochem (TSXV:SBM) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Sirona Biochem LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (TSXV:SBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Executives

Howard Jarman Verrico

Director, Senior Officer